CClinicalTrials.gg
Sign In
CompletedNCT03098849Updated May 9, 2018

Effectiveness of a Buteyko-based Breathing Technique for Asthma Patients

An interventional study of Buteyko Breathing Technique in Asthma, sponsored by ARCIM Institute Academic Research in Complementary and Integrative Medicine. Completed at 1 site in Germany. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-05-09.

Sponsored by ARCIM Institute Academic Research in Complementary and Integrative Medicine · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
63
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to investigate the effects of a Buteyko-based breathing technique on physiological and psychological parameters in adults with asthma

Read the detailed description

The investigators explore the effects of a Buteyko-based breathing technique training using a treatment group vs. control group design and a repeated measures design with follow-up measurements 3 and 6 months after the intervention. The sample size calculation was made for an effect of d = .20 with repeated measures, a power of 1- β = .80 and α = .05. Additionally the investigators plan to take measurements (only once) from healthy volunteers matching them (age and gender) with the asthma patients.

02

Conditions studied

  • Asthma

Browse trials for

Keywords

  • Buteyko-based breathing technique training
03

In context

Asthma

3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.

This study's enrollment of 63 is below the median of 83 across 2,752 interventional studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

ARCIM Institute Academic Research in Complementary and Integrative Medicine is the lead sponsor of 30 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Written informed consent, regular intake of prescribed asthma medication according to the AWMF scheme level 1, native speaker of german

Exclusion criteria

Exclusion Criteria:

  • Participation in another study, comorbidities (heart diseases, cancer still under treatment, psychiatric diseases)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
63 participants (actual)

Study arms

  • Experimental
    Buteyko Training

    Breathing exercises according to the Buteyko Breathing Technique

    Other: Buteyko Breathing Technique

  • No intervention
    Control Group

    Standard care as usual

Interventions

  • OtherButeyko Breathing Technique

    Patients are trained in various exercises aiming at breath reduction and breath control as introduced by Dr. K. Buteyko

06

What researchers measure

Primary outcomes

  1. Change in Endtidal CO2

    Capnometry

    Time frame: Between baseline and 3 month follow up

  2. Change in Nijmegen-Score

    Questionnare assessing hyperventilation

    Time frame: Between baseline and 3 month follow up

  3. Change in Buteyko CP

    Breath hold test

    Time frame: Between baseline and 3 month follow up

Secondary outcomes

  1. Spirometry: FEV1

    FEV1

    Time frame: Between baseline and 3 month follow up

  2. Spirometry: FEV1

    FEV1

    Time frame: Between baseline and 6 month follow up

  3. Spirometry: FEV1/VCin

    FEV1/VCin

    Time frame: Between baseline and 3 month follow up

  4. Spirometry: FEV1/VCin

    FEV1/VCin

    Time frame: Between baseline and 6 month follow up

  5. Spirometry: PEF

    PEF

    Time frame: Between baseline and 3 month follow up

  6. Spirometry: PEF

    PEF

    Time frame: Between baseline and 6 month follow up

  7. Heart Rate Variability (SDNN)

    SDNN

    Time frame: Between baseline and 3 month follow up

  8. Heart Rate Variability (SDNN)

    SDNN

    Time frame: Between baseline and 6 month follow up

  9. Heart Rate Variability (RMSSD)

    RMSSD

    Time frame: Between baseline and 3 month follow up

  10. Heart Rate Variability (RMSSD)

    RMSSD

    Time frame: Between baseline and 6 month follow up

  11. Heart Rate Variability (LF/HF)

    LF/HF

    Time frame: Between baseline and 3 month follow up

  12. Heart Rate Variability (LF/HF)

    LF/HF

    Time frame: Between baseline and 6 month follow up

  13. Vascular stiffness

    Pulse Wave Velocity

    Time frame: Between baseline and 3 month follow up

  14. Vascular stiffness

    Pulse Wave Velocity

    Time frame: Between baseline and 6 month follow up

  15. Blood Pressure

    Systolic and Diastolic

    Time frame: Between baseline and 3 month follow up

  16. Blood Pressure

    Systolic and Diastolic

    Time frame: Between baseline and 6 month follow up

  17. Haemodynamics Stroke volume

    Stroke volume

    Time frame: Between baseline and 3 month follow up

  18. Haemodynamics Stroke volume

    Stroke volume

    Time frame: Between baseline and 6 month follow up

  19. Haemodynamics Cardiac output

    Cardiac output

    Time frame: Between baseline and 3 month follow up

  20. Haemodynamics Cardiac output

    Cardiac output

    Time frame: Between baseline and 6 month follow up

  21. Haemodynamics Total Vascular Resistance

    Total Vascular Resistance

    Time frame: Between baseline and 3 month follow up

  22. Haemodynamics Total Vascular Resistance

    Total Vascular Resistance

    Time frame: Between baseline and 6 month follow up

  23. Haemodynamics Cardiac index

    Cardiac index

    Time frame: Between baseline and 3 month follow up

  24. Haemodynamics Cardiac index

    Cardiac index

    Time frame: Between baseline and 6 month follow up

  25. Haemodynamics Perfusion

    Perfusion index

    Time frame: Between baseline and 3 month follow up

  26. Haemodynamics Perfusion

    Perfusion index

    Time frame: Between baseline and 6 month follow up

  27. Haemodynamics Plethvariability

    Plethvariability index (PVI)

    Time frame: Between baseline and 3 month follow up

  28. Haemodynamics Plethvariability

    Plethvariability index (PVI)

    Time frame: Between baseline and 6 month follow up

  29. Oxygen Saturation

    SpO2

    Time frame: Between baseline and 3 month follow up

  30. Oxygen Saturation

    SpO2

    Time frame: Between baseline and 6 month follow up

  31. ACQ

    Asthma Control Questionnaire, E. Juniper

    Time frame: Between baseline and 3 month follow up

  32. ACQ

    Asthma Control Questionnaire, E. Juniper

    Time frame: Between baseline and 6 month follow up

  33. AQLQ

    Asthma Quality of Life Questionnaire, E. Juniper

    Time frame: Between baseline and 3 month follow up

  34. AQLQ

    Asthma Quality of Life Questionnaire, E. Juniper

    Time frame: Between baseline and 6 month follow up

  35. ARCIM Questionnaire

    Questionnaire focusing on respiratory complaints like mucus, snoring, blocked nose.

    Time frame: Between baseline and 3 month follow up

  36. ARCIM Questionnaire

    Questionnaire focusing on respiratory complaints like mucus, snoring, blocked nose.

    Time frame: Between baseline and 6 month follow up

  37. STAI Questionnaire

    State and Trait Anxiety Inventory

    Time frame: Between baseline and 3 month follow up

  38. STAI Questionnaire

    State and Trait Anxiety Inventory

    Time frame: Between baseline and 6 month follow up

  39. ASF Questionnaire

    "Aachener Selbstwirksamkeitsfragebogen"

    Time frame: Between baseline and 3 month follow up

  40. ASF Questionnaire

    "Aachener Selbstwirksamkeitsfragebogen"

    Time frame: Between baseline and 6 month follow up

  41. Asthma medication

    Kind and dosage of asthma specific medication like steroids or betamimetics

    Time frame: Between baseline and 3 month follow up

  42. Asthma medication

    Kind and dosage of asthma specific medication like steroids or betamimetics

    Time frame: Between baseline and 6 month follow up

07

Study locations

1 site
  • ARCIM Institute
    Filderstadt, Baden Württemberg 70794, Germany
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 9, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03098849
Lead sponsor
ARCIM Institute Academic Research in Complementary and Integrative Medicine
Collaborators
University Hospital Tuebingen
Responsible party
Sponsor
First posted
Apr 4, 2017
Start date
Jan 25, 2017
Primary completion
Oct 26, 2017
Completion
Oct 26, 2017
Last update
May 9, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Asthma→

Other studies from this sponsor

ARCIM Institute Academic Research in Complementary and Integrative Medicine

Start the discussion